key: cord-0806144-s6femdeq
authors: Chathuranga, Kiramage; Weerawardhana, Asela; Dodantenna, Niranjan; Lee, Jong-Soo
title: Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing
date: 2021-11-16
journal: Exp Mol Med
DOI: 10.1038/s12276-021-00691-y
sha: 848b66b785e452c0ec23283c6bec5ef99c16243a
doc_id: 806144
cord_uid: s6femdeq

A harmonized balance between positive and negative regulation of pattern recognition receptor (PRR)-initiated immune responses is required to achieve the most favorable outcome for the host. This balance is crucial because it must not only ensure activation of the first line of defense against viral infection but also prevent inappropriate immune activation, which results in autoimmune diseases. Recent studies have shown how signal transduction pathways initiated by PRRs are positively and negatively regulated by diverse modulators to maintain host immune homeostasis. However, viruses have developed strategies to subvert the host antiviral response and establish infection. Viruses have evolved numerous genes encoding immunomodulatory proteins that antagonize the host immune system. This review focuses on the current state of knowledge regarding key host factors that regulate innate immune signaling molecules upon viral infection and discusses evidence showing how specific viral proteins counteract antiviral responses via immunomodulatory strategies.

Viruses need to hijack the host cell machinery to replicate effectively; however, they must first overcome the host's defenses. The efficacy of a viral infection depends on the comparative potency of the effector molecules used by the virus and the host. A critical determinant of whether a host succumbs to or can subvert a viral infection is the speed at which the host's defenses are activated 1 . Almost all innate immune responses require an extended sequence of actions: pathogen sensing, signal transduction, transcription, translation, protein folding, and transport to the site of action. To initiate signaling upon viral infection, host cells detect viral DNA or RNA using a set of PRRs; these include retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), toll-like receptors (TLRs), nucleotidebinding oligomerization domain (NOD)-like receptors (RNA sensors), cyclic GMP-AMP (cGAMP) synthase (cGAS), interferon gamma inducible protein 16 (IFI16), absent in melanoma 2 (AIM2), and dead-box helicase 41 (DDX41) (DNA sensors) 2, 3 .

Recognition of viral nucleic acids by PRRs triggers transduction of downstream signals mainly via adaptor proteins such as mitochondrial antiviral signaling protein (MAVS) or stimulator of interferon genes (STING), which induce expression of interferon (IFN)-stimulated genes via autocrine or paracrine mechanisms; the products of genes (proinflammatory cytokines, chemokines, and IFNs) inhibit viral replication and spread and induce activation of adaptive immune responses 4, 5 . These antiviral signaling pathways play a crucial role in achieving an optimal outcome for the host; therefore, much attention has been devoted to identifying and understanding the signaling pathways and regulatory factors involved in antiviral innate immunity 6 (Figs. 1, 2) .

Conventional posttranslational modifications such as polyubiquitination and phosphorylation, unconventional posttranslational modifications such as acetylation and methylation, and other regulatory mechanisms such as physical interactions and translocations affect the production of IFN-β and inflammatory cytokines by targeting innate immune sensors and downstream signaling molecules (e.g., receptors, adaptors, enzymes, and transcription factors) 7, 8 . These aforementioned modifications play a critical role in regulating the production of IFNs and inflammatory cytokines, which can, if production is unchecked, have deleterious effects on the host by promoting the development of autoimmune disorders, allergies, and other immunopathologies, as well as by activating and regulating the cellular status to exacerbate the severity of viral disease 9 .

It is not surprising that viruses exploit numerous strategies to enhance their replication. To establish efficient, lifelong infection and to initiate viral pathogenesis, a large portion of the viral genome encode numerous immunomodulatory proteins; the function of these proteins is to evade/disrupt the host immune system and ensure viral persistence 10 . From the perspective of the virus, these actions are critically important because viruses depend on living cells for replication. This review focuses on current knowledge regarding two factors. First, we summarize the posttranslational modifications (PTMs) and other regulatory mechanisms of signaling molecules downstream of the RNA/DNA sensing cascade that regulate efficient IFN responses and/or maintenance of host immune homeostasis. Second, we summarize how RNA/DNA viruses evade transduced host innate immune signals, which are initiated by PRRs, to establish a permissive state in host cells.

PTMs play an important role in regulating the stability, activity, subcellular localization, and folding of proteins. Advances in experimental techniques used to map and quantify PTMs have led to marked progress in these areas. Such techniques have identified a number of PTMs that alter the innate immune response by regulating protein function, abundance, catalysis, interactions, or subcellular localization without necessarily requiring induction of a new transcriptional program 8, 11 . Additionally, some of these PTMs are highly dynamic and fully reversible, allowing both initiation and resolution of responses. Phosphorylation, a process by which a phosphoryl group is attached to a serine, threonine, tyrosine, histidine, or aspartate residue, is a well-studied PTM regulated by the opposing actions of protein kinases and phosphatases; this PTM plays an important role in innate immunity 11, 12 . The introduction of a phosphoryl group imparts a negative (-2) charge at physiological pH, resulting in a major biophysical perturbation of protein structure. This is manifested by conformational changes that alter enzymatic activity and/or protein-protein interactions 13 . Ubiquitination is another important PTM. During ubiquitination, proteins are modified via covalent attachment of a small 76-amino acid protein called ubiquitin, which (as the name implies) is expressed ubiquitously and is highly conserved in all eukaryotes 14 . Ubiquitination is inversely regulated by ubiquitin activating (E1), ubiquitin-conjugating (E2), and ubiquitin protein ligase (E3) enzymes and by deubiquitinating enzymes (DUBs); thus, it plays a critical role in regulating innate immune signal transduction. In contrast to phosphorylation, a single target site can be modified by a single ubiquitin molecule (monoubiquitination) or by chains of linked ubiquitin molecules (polyubiquitination) 15 . Ubiquitin chains can be classified topologically into one of four types according to architecture: homogeneous chains, multiple chains (in which one substrate is separately modified by distinct chains), mixed chains (in which a tandem chain contains two linkage types), and branched chains 16, 17 . Lysine 48 (K48)-linked polyubiquitination induces proteasomal degradation of the target protein, whereas K63-linked polyubiquitination mediates signal transduction 16, 17 . Monoubiquitination, linear polyubiquitination, and K6-, K11-, K27-, K29-, and K33-linked ubiquitination are being investigated intensely to determine their divergent roles in innate immunity 15 . Similar to conventional PTMs, unconventional PTMs also play a role in innate immune signal transduction 8 . The transfer of acetyl groups from acetyl coenzyme A (acetyl-CoA) to the ε amino acid groups of lysine residues (a process termed acetylation) results in charge neutralization, which alters the biological properties of proteins; in addition, lysine and arginine residues are inversely regulated by methyltransferases (a process termed methylation) and demethylases, and both acetylation and methylation play important roles in innate immune signaling 18 . Below we summarize the PTMs and other regulatory mechanisms of signaling molecules downstream of the RNA/DNA sensing cascade (also see Tables 1, 2, and 3) . 

Viruses that have evolved with their host develop strategies to evade the innate immune system and ensure their replication and survival. Individual viruses or virus families use different strategies. This review explores the different mechanisms used by RNA and DNA viruses to subvert the functions of individual signaling molecules in the type 1 interferon (IFN) pathway. Many viruses use proteases to cleave target proteins 19 , while some viral proteins promote the degradation of target innate immune signaling molecules 20, 21 . Furthermore, viral deubiquitinase enzymes remove K63-linked polyubiquitin chains from signaling molecules to prevent their activation 22, 23 , and viral E3 ubiquitin ligases transfer K48-linked polyubiquitin moieties to target molecules to trigger their proteasomal degradation 24 . Some viral proteins recruit host E3 ubiquitin ligases to polyubiquitinate signaling molecules and increase their proteasomal degradation 25 . The formation of signaling molecule complexes is crucial for downstream transduction of innate immune signals. Direct interactions with viral proteins inhibit the formation of signaling complexes such as the TRAF3, TANK, and TBK1 complexes 26, 27 . Another important mechanism of immune evasion is physical interaction between viral proteins and host signaling molecules, which prevents activation, dimerization, phosphorylation, or nuclear translocation 28, 29 . Below, we summarize the mechanisms underlying innate immune evasion mediated by viral proteins (also see Tables  4 and 5) .

RLR (RIG-I-like receptor) family receptors are the main PRRs that detect intracellular viral RNA 30, 31 . The RLR family comprises RIG-I, melanoma differentiation-associated gene 5 (MDA5), and laboratory of genetics and physiology 2 (LGP2). RIG-I and MDA5 are typical PRRs, whereas LGP2 is a regulator of RIG-I and MDA5 mediated signal transduction 32, 33 . RIG-I and MDA5 contain two N-terminal caspase-recruitment domains 34 , a central DExD/H-box helicase domain, and a C-terminal domain (CTD). RIG-I and MDA5 bind to viral RNA in the cytoplasm via an RNA binding motif 30, 31 , after which the signaling domain interacts with the downstream adaptor molecule MAVS via a CARD-CARD-mediated interaction. This interaction causes aggregation of MAVS to form a prion-like protein complex, which relays the signal to kinases such as TANKbinding kinase 1 (TBK-1) and IĸB kinase-ε (IKKε). Activation of this cascade results in phosphorylation of the transcription factors IFNregulating factor (IRF)-3 and IRF-7 31, 35, 36 . Finally, nuclear translocation of IRF-3 and IRF-7 induces the expression of type 1 IFN genes and other antiviral genes 37 . However, RNA viruses employ strategies to evade these RLR-mediated innate immune responses. Below, we describe the activation and regulatory mechanisms of 

Phosphorylation and promotes K63-linked ubiquitination 116 Negative ERα K48-linked ubiquitination 128 the major innate signaling molecules, along with the immunomodulatory mechanisms by which viruses evade them.

MAVS, also called IPS1, VISA, and CARDIF, is a key adaptor protein for RIG-I-like receptor-initiated signal transduction. Upon viral infection, RIG-I and MDA5 bind to MAVS, thereby activating downstream signal transduction. The MAVS protein, which contains 540 amino acids encoded by the nuclear genome 38 , is localized predominantly on the mitochondrial outer membrane. However, experimental evidence shows that it also localizes to mitochondrial-associated endoplasmic reticulum membranes and peroxisomes [39] [40] [41] . MAVS contains three domains: a CARD, a middle proline-rich region, and a C-terminal transmembrane 42 domain. The CARD interacts with CARDs in RIG-I and MDA5, activating MAVS, whereas the proline-rich region interacts with the tumor necrosis factor receptor-related factor (TRAF) family members TRAF2, TRAF3, TRAF5, and TRAF6 to activate downstream signaling 43 . The TM domain plays a crucial role by ensuring the localization of MAVS to the mitochondrial outer membrane 44 . Upon binding to the CARDs of RIG-I and MDA5, MAVS rapidly forms prion-like aggregates, which convert other MAVS proteins present on the mitochondrial outer membrane into prion-like aggregates 45 . Activation of MAVS through aggregation recruits TRAF2, TRAF3, TRAF5, and TRAF6 via the PRR to promote the formation of the TBK1 complex (comprising TBK1, IĸB kinase, IKKε, and NEMO) 46 . It is not surprising that the expression of MAVS is regulated to ensure that RLR-mediated signaling cascades are not activated rapidly upon stimulation; indeed, its function at this stage of viral infection is to prevent rapid viral replication.

Self-association and prion-like aggregate formation are markers of MAVS activation 45 . The E3 ubiquitin ligase Tripartite motifcontaining protein (TRIM) 31 interacts with MAVS and catalyzes K63-linked polyubiquitination of aa residues K10, K311, and K461 in MAVS to promote the formation of aggregates. Interestingly, this phenomenon occurs upon viral infection in the presence of RIG-I; thus, recruitment of RIG-I may be required for TRIM31mediated MAVS aggregation upon viral infection 47 52, 53 .

Phosphorylation is an important PTM that regulates MAVS signaling. Activated MAVS recruits TBK1 and IKKε to the complex. These kinases mediate the phosphorylation of MAVS, enabling the recruitment of IRF3. Recruited IRF3 is phosphorylated by TBK1, which increases its homodimerization and nuclear translocation. Similar to PTMs, non-PTMs play a crucial role in regulating MAVS signaling 12 . Importantly, TRAF3 interacts with MAVS (aa 450-468), 56 . In addition, focal adhesion kinase (FAK) interacts with MAVS at the mitochondrial membrane in a viral infection-dependent manner to potentiate MAVS-mediated signaling via a kinase-independent mechanism 57 . Negative regulation of MAVS is mediated mainly by K48-linked ubiquitination of MAVS, signaling blockade, autophagy, and apoptosis. K48-linked polyubiquitination of MAVS triggers its proteasomal degradation and abrogates RLR-mediated signal transduction. Experimental evidence has shown that several E3 ubiquitin ligases are involved in K48-linked ubiquitination of MAVS and its proteasomal degradation; these ligases include Ring finger protein 5 (RNF5), RNF115, TRIM25, Smurf1, Smurf2, von Hippel-Lindau protein (pVHL), and membrane-associated RING finger protein 5 (MARCH5) 52, [58] [59] [60] [61] [62] [63] . Importantly, the ubiquitin thioesterase OTU1 (YOD1) cleaves the K63-linked ubiquitin moiety and abrogates the formation of prion-like aggregates by MAVS, thereby attenuating IRF3-mediated production of IFN-β 64 . Moreover, interactions between several proteins mediate MAVS ubiquitination and degradation via recruitment of E3 ubiquitin ligases. For example, poly(RC) binding protein 1/2 (PCBP1/PCBP2)and tax1-binding protein 1 (TAX1PB1)-mediated K48-linked ubiquitination of MAVS via AIP4/ITCH triggers proteasomal degradation of MAVS 50, 65, 66 . Similarly, Smurf1-mediated K48linked ubiquitination is upregulated by OTUD1 67 . The E3 ubiquitin ligase RNF125 conjugates ubiquitin to MAVS, thereby suppressing its function, and K27-linked ubiquitination of MAVS mediated by the E3 ubiquitin ligase MARCH8 recruits the autophagy protein NDP52, resulting in lysosomal degradation of MAVS 68, 69 . Additional mechanisms that negatively regulate MAVS-mediated RLR signaling are phosphorylation and degradation of MAVS via Nemo-like kinase (NLK) 70 . Protein phosphatase magnesiumdependent 1A (PPM1A; also called PP2Cα) is an inherent component of the TBK1/IKKε complex, which targets both MAVS and TBK1/IKKε for dephosphorylation, thereby disrupting MAVSdriven formation of the signaling complex 71 .

Direct protein-protein interactions and signal blockade are other mechanisms that downregulate MAVS-mediated RLR 115 . The serine-threonine kinase CK1ɛ interacts with TRAF3 and phosphorylates it on Ser349, which promotes Lys63 (K63)-linked ubiquitination of TRAF3 and subsequent recruitment of the kinase TBK1 to TRAF3 116 . Osteopontin (OPN) interacts with TRAF3 to inhibit Triad3A-mediated K48-linked polyubiquitination and degradation of TRAF3 117 . Downstream of kinase 3 (DOK3) interacts with TRAF3 through its tyrosine-rich CTD to induce TRAF3/TBK1 complex formation 118 , whereas the interaction Since K63-linked polyubiquitination plays an important role in TRAF3-mediated signaling, it comes as no surprise to see that viruses encode proteins that inhibit TRAF3 ubiquitination to overcome host innate responses. The leader proteinase (Lpro) of FMDV 133 and the ubiquitin-specific protease (UL36) of herpes simplex virus 1 (HSV-1) 134 act as viral deubiquitinases that mediate TRAF3 deubiquitination, leading to downregulation of TRAF3 signaling. The nonstructural protein 2A protease (2Apro) of human enterovirus D68 (EV-D68) cleaves TRAF3 at G462 135 . The M protein of SARS-CoV forms a complex with TRAF3, TANK, and the TBK1/IKKε complex to inhibit TBK1/IKKε-dependent activation of the IRF3/IRF7 transcription factors 27 .

NF-κB essential modulator (NEMO or IKKγ), which contains 419 aa, is the integral regulatory scaffolding protein of the canonical IKK complex located at the center of both the NF-κB and type I IFN signaling cascades 136 . The IKK complex comprises two kinases, IKKα and IKKβ, and a regulatory subunit, NEMO 137 . For appropriate assembly of the IKK complex, NEMO contains two coiled-coil domains (CC1 and CC2) at its N-terminus upstream of a leucine zipper and a C-terminal zinc finger (ZF) domain. In response to RLR signaling, ubiquitinated TBK1 recruits the adaptor protein NEMO via the ubiquitin binding domain. Assembly of the NEMO/TBK1 complex on MAVS activates the TBK1 kinase and phosphorylation of IRF3 138 . As NEMO plays a critical role in regulating RLRmediated IFN signaling, several positive and negative host 144 . Additionally, the HAV 3C protease (3Cpro) cleaves NEMO at Q304, thereby abolishing its signaling adaptor function and abrogating the induction of IFN-β synthesis 145 . NSP4, a viral 3C-like serine protease of PRRSV, cleaves NEMO at E166, E171, and E349-S350, while NSP4 of equine arteritis virus, which is similar to NSP4 of PRRSV, cleaves NEMO at E166, E171, Q205, and E349 to inhibit downstream signaling and maintain viral infection 146, 147 . NSP5 of feline infectious peritonitis virus and NSP5 encoded by porcine epidemic diarrhea virus (PEDV) cleave NEMO at Q132, Q205, Q231, and Q231, resulting in downregulation of immune signaling 148, 149 . Similarly, NSP5 of porcine deltacoronavirus (PDCoV) cleaves NEMO at Q231 to impair the ability of NEMO to activate the IFN response and downstream signaling 150 . Furthermore, ORF9b of SARS-CoV-2 disrupts K63linked polyubiquitination of NEMO 151 , thereby downregulating IFN production during SARS-CoV-2 infection.

TRAF family member-associated NF-κB activator (TANK)-binding kinase 1 (TBK1, also called NAK or T2K) is one of two noncanonical IKKs implicated in regulating the activation of IRF3/IRF7 and the NF-κB signaling pathway. TBK1 is a 729 aa protein (84 kDa) containing an N-terminal kinase domain (KD), a ubiquitin-like domain (ULD), and two C-terminal coiled-coil domains 152 . The ULD acts as a regulatory domain by binding to the functional domains of TBK1 as well as to substrates such as IRF3/IRF7, thereby enabling the KD to phosphorylate target substrate proteins. Furthermore, the structure of TBK1 is similar to that of the noncanonical kinase IKKε; indeed, both kinases always work together. Cellular expression of TBK1 is ubiquitous; thus, it plays an indispensable role in antiviral innate immunity. Upon infection with RNA viruses, TBK1 is activated by the upstream protein MAVS, and activated TBK1 recruits IRF3 and IRF7; these proteins undergo TBK1-mediated C-terminal phosphorylation to trigger their dimerization and nuclear translocation, an event followed by induction of IFN secretion 153 .

As a vital kinase that regulates the activation of IRF3/IRF7 and the subsequent expression of IFN, the function of TBK1 must be regulated to maintain immune homeostasis and suppress viral replication. Therefore, several regulatory factors target TBK1 to control its function, while viruses have evolved mechanisms to disable it. Moreover, TRAF family E3 ubiquitin ligase-mediated K63-linked polyubiquitination of intact dimerized TBK1 at Lys30 and Lys401 154 results in transautophosphorylation on Ser172, which marks TBK1 for phosphorylation-mediated activation 155 . Glycogen synthase kinase 3β (GSK3β) facilitates the aforementioned autophosphorylation of TBK1 at Ser172 156 . TRIM9 short isoform (TRIM9s) facilitates the recruitment of GSK3β to TBK1 upon viral infection 157 , and Raf kinase inhibitory protein serves as a positive regulator 158 ; both of these proteins promote autophosphorylation of TBK1. Moreover, ubiquilin 2 (UBQLN2) promotes the stability and facilitates the phosphorylation of TBK1 159 , and Tyr179 (Y179) phosphorylation (catalyzed by the tyrosine kinase Src) is essential for the initiation of TBK1 autophosphorylation 160 . Ubiquitination also plays a critical role in the activation of TBK1. Mindbomb E3 ubiquitin-protein ligase 1 (MIB1) and MIB2 161 , ring finger protein 128 (RNF128) 162 , and neuregulin receptor degradation protein 1 (Nrdp1/RNF41) 163 activate TBK1 by promoting its K63-linked ubiquitination. The deubiquitinase complex comprising ubiquitin-specific peptidase 1 (USP1) and USP1-associated factor 1 (UAF1), binds to TBK1 to remove K48-linked polyubiquitination and reverse the degradation process 164 . The DNA methyltransferase Dnmt3a maintains high expression of the histone deacetylase HDAC9, which maintains deacetylation of TBK1 and increases its kinase activity 165 , whereas HDAC3 positively regulates TBK1 in the same manner as HDAC9 166 . Moreover, butyrophilin 3A1 (BTN3A1) interacts with TBK1 to facilitate its dynein-dependent transport to the perinuclear region to promote its association with IRF3 after viral infection 167 . IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) mediates the bridging of TBK1 to MAVS on mitochondria 168 . Additionally, the E3 ubiquitin ligase TRIM26 bridges the interaction between NEMO and TBK1, which facilitates immune activation upon viral infection 169 . Moreover, the homeobox protein MSX1 and docking protein 3 (DOK3) positively regulate TBK1 function to facilitate complex formation, and PLA1A upregulates TBK1 recruitment to mitochondria via modulation of mitochondrial morphology 118, 170, 171 .

In contrast, several TBK1-regulating proteins negatively impact TBK1. K48-linked polyubiquitination of TBK1 induced by E3 ubiquitin ligases such as SOCS box-containing 8 (ASB8) 172 , TRAFinteracting protein 173 , dual-specificity tyrosine phosphorylationregulated kinase 2 (DYRK2) 174 , and THO complex subunit 7 homolog (THOC7) 175 triggers proteasomal degradation of TBK1 and ultimately terminates immune activation. Interestingly, USP38 permits K48-linked ubiquitination and subsequent degradation of TBK1 by specifically removing K33-linked ubiquitin chains from the same lysine site on TBK1 176 . Additionally, Siglec1 recruits TRIM27 and NLRP4 recruits DTX4 to trigger K48-linked polyubiquitination of TBK1 177, 178 . As noted above, K63-linked polyubiquitination plays a crucial role in activating TBK1. Therefore, any protein that disrupts the ubiquitin chain can be considered a negative regulator. For example, the deubiquitinating enzyme cylindromatosis (CYLD) removes K63-linked polyubiquitin moieties from TBK1 34 , and the A20 regulatory complex (comprising the ubiquitin-editing enzyme A20, Tax1-binding protein 1 (TAX1BP1, also called T6BP or TXBP151) 179 , and ubiquitin-specific protease (USP) 2b (USP2b) 180 antagonize K63-linked polyubiquitination of TBK1. Moreover, UBE2S recruits USP15 to TBK1, thereby removing K63-linked polyubiquitin chains 181 . The Src family kinases Lck, Hck, and Fgr phosphorylate TBK1 directly at Tyr354/394 to prevent its dimerization and activation 182 . The ADP-ribosylase TIPARP interacts with TBK1 to suppress its activity via ADP-ribosylation 183 . The phosphatase Cdc25A dephosphorylates TBK1 at its activation site (S172) upon viral infection 184 . Moreover, upon infection with RNA viruses, protein phosphatase 1B (PPM1B) 185 , Cdc25A 184 , and protein phosphatase 4 (PP4) 186 dephosphorylate Ser172 of TBK1 to prevent continuous activation of TBK1. Preventing protein-protein interactions is another method of inhibiting TBK1-driven immune activation. NOD-like receptors (e.g., NLRP2) 187 and estrogen-related receptor α (ERRα) 188 inhibit the interaction between TBK1 and IRF3, while MIP-T3 189 prevents the formation of the TRAF3/TBK1 complex. Additionally, ISG56 disrupts the interaction between MITA and VISA or TBK1, while INKIT interacts with TBK1 to impair the recruitment and phosphorylation of IRF3 190, 191 .

TBK1 is targeted by viruses to modulate innate immune activation and ensure viral survival and persistent replication. SARS-CoV-2 virus NSP13 192 , Heartland virus (HRTV) NS 193 , and dengue virus (DENV) serotype 4 (DENV4) NS 194 proteins interact directly with TBK1 to prevent its autophosphorylation. Papain-like protease domain 2 (PLP2) of mouse hepatitis virus A59 (MHV-A59) 195 and the short form leader proteinase (Lpro) Lbpro of FMDV 133 cleave ubiquitin chains from TBK1 and inactivate its kinase activity. The Us11 protein of HSV-1 interacts with Hsp90, which competes with TBK1 to disrupt the formation of the TBK1/Hsp90 complex. Us11 subsequently mediates TBK1 destabilization via a proteasome-dependent pathway 196 . Severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) escapes the host immune system by inducing the formation of cytoplasmic inclusion bodies with the help of NS proteins 197, 198 , whereas the NS protein of SFTSV impairs the autophosphorylation of TBK via a direct interaction 199 . Moreover, the N protein of PEDV 200 and the NS protein of HRTV 201 inhibit the TBK1/IRF3 interaction by targeting TBK1 directly, while the NS5 protein of Zika virus antagonizes IFN production by blocking TBK1 activation 202 . A recent study demonstrated that NSP13 of SARS-CoV-2 interacts directly with the MAVS binding domain of TBK1 and disrupts the TBK1-MAVS interaction 203 . Membrane-anchored PLpro domain (PLpro-TM) of SARS-CoV inhibits STING/TBK1/IKKε-mediated activation of type I IFNs by disrupting the phosphorylation and dimerization of IRF3 204 . FLIPs (MC159 and MC160) encoded by molluscum contagiosum virus inhibit TBK1 phosphorylation and activation; however, MC159 interacts directly with TBK1, whereas MC160 does not 205 . Grass carp reovirus (GCRV) inhibits TBK1 activation by removing K63-linked ubiquitination from TBK1 and promoting its K48-linked ubiquitination 24 .

IKKε (originally called IKKi) is a noncanonical member of the IκB kinase family that has been studied extensively due to its ability to promote type I IFN responses. IKKε is a 716 aa protein comprising a KD, a ULD, and a scaffold dimerization domain. The KD of IKKε shares 49% identity and 65% similarity with that of TBK1 206 . Activation of TBK1 and IKKε promotes phosphorylation and nuclear translocation of IRF3 and 7, leading to transcriptional upregulation of type I IFNs during the induction of the innate immune response 207 . During the innate immune response, TBK1 and IKKε exhibit functional redundancy, although TBK1 appears to be more important than IKKε. The IKK subunit NEMO promotes activation of TBK1 and IKKε downstream of cytoplasmic DNA signaling, whereby ubiquitinated NEMO recruits IKKβ to facilitate activation of TBK1 or IKKε.

Biochemical analysis has revealed that the interaction between sphingosine 1-phosphate (S1P) lyase and IKKε leads to IKKε-driven activation of IFN signaling 208 . Viral infection triggers an interaction between DDX3 and IKKε. Expression of DDX3 amplifies TBK1/IKKεmediated induction of the IFN-β promoter 209 . DExD/H-box RNA helicase 19 (DDX19) recruits Lamtor2 to form the TBK1/IKKε/ Lamtor2/DDX19/IRF3 complex, which suppresses IFN production by promoting degradation of TBK1 and IKKε 210 . Fascin1, an actinbundling protein, interacts with IKKε to suppress the RIG-Imediated signaling cascade in colon cancer cells 211 .

To date, few studies have been conducted on viral proteins that interfere with the signaling mechanisms of IKKε. NS2B/3 of DENV interacts directly with IKKε; computational analysis revealed that via this interaction, NS2B/3 masks the KD of IKKε and potentially affects its functionality, thereby impairing the phosphorylation and nuclear translocation of IRF3 212 . Interestingly, NS2 of HCV interacts physically with the IKKε/TBK1 kinase complex, thereby inhibiting IRF3 phosphorylation 213 . Moreover, the VP35 protein of Ebola virus (EBOV) interacts with IKKε and TBK1 during the early  phase of viral infection; this physical interaction with IKKε further  prevents the interaction of IKKε with IRF3, IRF7, and MAVS 214 . Similarly, lymphocytic choriomeningitis virus (LCMV) NP binds to the KD of IKKε to block its autocatalytic activity and its ability to phosphorylate IRF3 215 . Additionally, ORF8b of Middle East respiratory syndrome coronavirus (MERS-CoV) inhibits HSP-70dependent IKKε activation, while NS2 of HCV inhibits IKKεdependent phosphorylation of IRF3 213, 216 .

IRF3 (also called IIAE7) is a master transcription factor responsible for the induction of innate antiviral immunity. It is a 427 aa (47.219 kDa) protein that is expressed ubiquitously in tissues. IRF3 contains an N-terminal DNA binding domain (DBD) and a C-terminal transactivation domain. After considerable research, TBK1 and IKKε were identified as the kinases responsible for IRF3 phosphorylation at its C-terminus, which facilitates the formation of dimers that are then transported to the nucleus 136, 217 to form a complex with coactivators of the p300/CBP family and initiate the transcription of target genes, including the gene encoding IFNβ 218,219 . IRF3 contains an active nuclear localization signal that is recognized by importin-α receptors and results in its transport into the nucleus 219, 220 .

Because IRF3 is crucial for RLR-mediated antiviral immune activation, it is not surprising that IRF3 function is both positively and negatively regulated by host proteins or that viruses have evolved mechanisms to abolish protein expression. The long noncoding RNA (lncRNA) lncLrrc55-AS recruits methylesterase 1 (PME-1) to promote the interaction between PME-1 and the phosphatase PP2A, an inhibitor of IRF3 phosphorylation 221 . Similarly, IRF1 interacts with IRF3 to augment the activation of IRF3 by blocking the interaction between IRF3 and PP2A 222 . Heat shock protein family D (Hsp60) member 1 facilitates the phosphorylation and dimerization of IRF3 and increases IFN-β induction induced by SeV infection 61 . The lysine methyltransferase nuclear receptor-binding SET domain 3 (NSD3) binds directly to the IRF3 C-terminal region through its PWWP1 domain and methylates IRF3 at K366. Monomethylation maintains IRF3 phosphorylation by promoting the dissociation of IRF3 from the protein phosphatase PP1cc, thereby promoting the production of type I IFNs 223 . The deubiquitinating enzyme USP22 deubiquitinates and stabilizes KPNA2 after viral infection, thereby facilitating efficient nuclear translocation of IRF3 224 .

Regarding the negative regulation of IRF3-mediated signaling, the E3 ubiquitin ligase interacting protein peptidyl-prolyl cis/trans isomerase, NIMA-interacting 1 225 , and RBCC protein interacting with PKC1 (RBCK1) 226 , Ro52/TRIM21 227 , the HECT domain ubiquitin 228 E3 ligase RAUL 229 , and TRIM26 230 catalyze the K48-linked polyubiquitination and subsequent proteasomal degradation of IRF3. Moreover, OTUD1 removes viral infection-induced K6-linked ubiquitin moieties from IRF3, resulting in dissociation of IRF3 from the promoter region of its target genes without affecting its protein stability, dimerization, or nuclear translocation 231 . IFNinduced transmembrane protein 3 (IFITM3) associates with IRF3 and regulates the homeostasis of IRF3 by mediating its autophagic degradation 232 . Phosphorylation of IRF3 is the key modification that leads to its activation. Therefore, dephosphorylation of IRF3 via phosphatases such as MAPK phosphatase 5 (MKP5) 233 and the serine/threonine phosphatase PP2A 234 inactivates IRF3. However, Mst1 associates with IRF3 and phosphorylates IRF3 directly at Thr75 and Thr253, which prevents IRF3 homodimerization, reduces its ability to occupy chromatin, and dampens IRF3mediated transcriptional responses 235 . Interestingly, the F-box protein FBXO17 decreases IRF3 dimerization and nuclear translocation by recruiting protein phosphatase 2A (PP2A), resulting in dephosphorylation of IRF3 236 ; research suggests that the DDX5 protein facilitates this process during viral infection 237 . HDAC4 inhibits TBK1-and IKKε-mediated phosphorylation of IRF3 at Ser386 and Ser396 238 . Sentrin/SUMO-specific protease 2 (SENP2) causes IRF3 deSUMOylation, K48-linked ubiquitination, and degradation 239 . DEAD-box polypeptide 56 (DDX56) suppresses the nuclear translocation of IRF3 by disrupting the interaction between IRF3 and the nuclear translocation supporter IOP5 240 . Rubicon specifically interacts with the IRF association domain (IAD) of IRF3, which prevents dimerization of IRF3 241 . Human argonaute 2 (AGO2) blocks the association of IRF3 with CBP; however, this interaction does not affect the phosphorylation, nuclear translocation, or DNA binding of IRF3 242 .

Due to genomic constraints, the immunomodulatory efforts of most viruses focus on host targets that are key players in the antiviral response. It is not surprising, therefore, that IRF3 is one of these targets. The NS1 proteins of influenza A virus (IAV) 243 and porcine hemagglutinating encephalomyelitis virus (PHEV) 244 , the phosphoprotein (P) of rabies virus (RABV) 245 , the PLpro protein (with deubiquitination activity) of SARS-CoV-2, the NSP1β protein of PRRSV 228 , the N protein of Peste des petits ruminants virus (PPRV) 247 , and the NSP15 protein of PEDV 248 inhibit activation of IRF3 to downregulate nuclear translocation. A recent study reported that open reading frame 6 (ORF6) of SARS-CoV-2 binds to the importin karyopherin α 2 (KPNA2), thereby inhibiting the nuclear translocation of IRF3 192 ; in addition, the ORF6, NSP12, and NSP5 proteins inhibit the nuclear translocation of IRF3 to prevent IFN production 249, 250, 251 , while the NSP3/papain-like protease cleaves IRF3 to subvert IFN production 252 . Moreover, NS5 of Japanese encephalitis virus (JEV) interacts with the nuclear transport proteins KPNA2, KPNA3, and KPNA4, which competitively block the interactions between KPNA3 and KPNA4 and one of their cargo molecules, IRF3 253 . JEV downregulates IRF3 phosphorylation and nuclear translocation, an effect that became more pronounced when the molar ratio of sfRNA to genomic RNA was increased 254 . The V protein of Sendai virus (SeV) inhibits IRF3 translocation to the nucleus 255 , and the 3C pro protein of SVV degrades IRF3 via its protease activity 256 . The N pro protein of classical swine fever virus (CSFV) 257 and the NSP1 protein of RV 258 trigger proteasomal degradation of IRF3. FMDV 3A interacts with DDX56 to inhibit type I IFN production by reducing the phosphorylation of IRF3 259 . Hantavirus 260 oncoprotein Tax of human T-cell leukemia virus type 1 (HTLV-1) 261 , the NS protein of DENV 194 , and the M protein of MERS-CoV 262 downregulate IRF3 phosphorylation. Moreover, two reports revealed that the ML protein of Thogoto virus (THOV) and the NSP1 protein of RV block the dimerization and subsequent nuclear translocation of IRF3 263, 264 .

IRF7 is a 503 aa (55 kDa) protein containing an N-terminal DBD, an IAD, a nuclear export sequence, an autoinhibitory domain, and a signal response domain composed of key serine residues 217, 265 . Unlike IRF3, IRF7 is not expressed ubiquitously in cells; instead, its expression is induced upon pathogen infection or stimulation. However, it is a master regulator of type I IFN gene expression and IFN-dependent innate immune responses 266 . IKKε and TBK1 are the major kinases responsible for IRF7 phosphorylation and activation 267 . Nuclear translocation and accumulation of IRF7 trigger the induction of IFN-β and IFN-α expression 268 . K63-linked polyubiquitination of IRF7 on lysines 444, 446, and 452, a process that is important for its activation prior to its phosphorylation and nuclear translocation, is triggered by TRAF6 269 . Research has shown that the regulation of IRF7 activity by several negative regulators maintains immune homeostasis. N-Myc and STAT interactor (Nmi) promote K48-linked ubiquitination of IRF7 and its subsequent proteasome-dependent degradation 270 , whereas Ro52/TRIM21 mediates its ubiquitination-promoted degradation upon upstream signaling activation 271 . TRIM28 interacts with the SUMO E2 enzymes to increase the SUMOylation of IRF7. TRIM28mediated SUMOylation of IRF7 increases during viral infection, resulting in transcriptional repression 272 . The N-terminal deubiquitinase 273 domain of the enzyme A20 interacts physically with IRF7 to reduce its K63-linked ubiquitination and negatively regulate transcriptional function 274 . Moreover, physical interactions between IRF7 and the IFN-inducible p200 family protein IFI204 275 , activating transcription factor 4 (ATF4), and HSP70 276, 277 downregulate IRF7 activity, leading to downregulation of innate immune activation. Different RNA viral proteins inhibit IRF7. VP35 of EBOV increases PIAS1-mediated SUMOylation of IRF7, thereby repressing IFN transcription 278 . In addition, HCV infection impairs the nuclear translocation of IRF-7 279 . The Zn-binding domain of the CSFV N pro protein interacts directly with IRF7 to subvert its function 280 . In particular, 3C pro of SVV was found to reduce IRF7 protein expression and phosphorylation in PK-15 cells 256 .

Upon infection with DNA viruses, viral DNA is released into the host cell cytoplasm prior to viral protein synthesis. Cytosolic viral DNA is recognized mainly by cyclic GMP-AMP (cGAMP) synthase (cGAS), which contains a nucleotidyltransferase (NTase) domain. After DNA binding, cGAS synthesizes a second messenger molecule, cyclic GMP-AMP (cGAMP). This cGAMP isomer, called 2',3'-cGAMP, functions as a second messenger that binds to the ER membrane adaptor STING [281] [282] [283] to induce a conformational change that presumably results in activation of STING. STING then traffics from the ER to the ER-Golgi intermediate compartment and then to the Golgi apparatus 284, 285 . During this process, the carboxyl terminus of STING recruits and activates the kinase TBK1, which in turn phosphorylates the transcription factor IRF3. Phosphorylated IRF3 dimerizes and then enters the nucleus, ultimately leading to the induction of type 1 IFN genes and other antiviral genes 286 . Although other proteins, such as IFI16, DDX41, and MRE11, also mediate DNA-induced IFN-β production in a STING-dependent manner, only cGAS, which enzymatically generates cGAMP as a second messenger that activates STING, provides a clear molecular mechanism for DNA-stimulated IFN-β production 287 . However, DNA viruses exploit strategies to evade innate immune responses. Below, we describe the activation and regulation of these mechanisms, along with the immunomodulatory mechanisms by which viruses evade them.

Upon DNA recognition, cGAS generates the second messenger 2′,3′-cyclic GMP-AMP (2′,3′-cGAMP) by using ATP and GTP 284, 288 . Unlike the secondary messengers in classical bacterial signaling (cdi-GMP and c-di-AMP), 2′,3′-cGAMP contains mixed phosphodiester bonds (G(2′,5′)pA and A(3′,5′)pG) 282, 289 . The intermediate product, called 5′-pppG(2′,5′)pA, is generated by cGAS prior to synthesis of cyclic 2′,3′-cGAMP 42 . Next, 2′,3′-cGAMP interacts with STING to activate downstream signaling, resulting in strong induction of IFNs, which confer antiviral efficacy 288 . To date, few studies have examined host factors and viral proteins that regulate 2′,3′-cGAMP function during innate immune activation. A recent study of HSV-1 infection showed that Leucine-rich repeatcontaining protein (LRRC) LRRC8A/LRRC8E-containing volumeregulated anion channels transport cGAMP across the plasma membrane to initiate effective antiviral innate immunity 290 . In contrast, 2′,3′-cGAMP is hydrolyzed predominantly by ectonucleotide pyrophosphatase/phosphodiesterase (ENPP1), thereby preventing STING activation. In general, viruses have evolved mechanisms to antagonize host innate immune activation 291, 292 . However, the antiviral second messenger 2′,3′-cGAMP can be packaged into viral particles, including those of poxviruses, herpesviruses, and retroviruses, thereby enabling its transfer to newly infected cells, where it activates the immune response. Once 2′,3′-cGAMP-carrying virions infect neighboring cells, they activate a STING-dependent antiviral program 293, 294 . Moreover, the poxvirus immune nuclease (poxin) family, a family of 2′,3′-cGAMP-degrading enzymes, has been identified. Vaccinia virus poxin degrades 2′,3′-cGAMP through metal-independent cleavage of the 3′-5′ bond, thereby converting 2′,3′-cGAMP into linear Gp [2′-5′]Ap[3′]. Furthermore, the same study revealed that deletion of the poxin gene (B2R) attenuates vaccinia virus replication in vivo, thereby restricting STING-dependent signaling 295 .

STING, also called MITA, ERIS, TMEM173, or MPYS, is an ER membrane signaling 283 protein of 379 aa; it harbors a predicted TM portion (aa residues 1-173) at the N-terminus, which regulates its cellular localization and homodimerization, since the TM domains cross the ER membrane. It also harbors an intracellular soluble portion (aa residues 174-379) in the CTD, which functions to dock downstream molecules such as TBK1/IKKε and IRF3/ IRF7 296, 297 . To initiate signaling, the native ligand cGAMP binds to the V-shaped hydrophilic pocket in the STING dimer. The resulting conformational change exposes the hidden CTT of STING to TBK1 and IRF3 298, 299 . Due to this conformational change, STING is transported from the ER to the ER-Golgi intermediate compartment and then to the Golgi apparatus and perinuclear region 300 .

Since STING is essential for innate immune responses to cytosolic nucleic acids, its activity is tightly regulated to maintain immune homeostasis while enabling timely activation of downstream signaling to fight against viral infections. Several PTMs are involved in regulating STING function. Among them, K63-linked polyubiquitination plays a critical activating role. Mitochondrial E3 ubiquitin protein ligase 1 (MUL1) catalyzes K63-linked polyubiquitination of STING at K224 to transport TBK1 to IRF3. The ubiquitination-deficient STING mutant K224R fails to translocate to perinuclear puncta in response to a stimulus, suggesting that K63-linked polyubiquitination of STING at K224 is essential for STING trafficking 301 . The E3 ubiquitin ligases TRAF6 302 , ubiquitin regulatory X domain-containing protein-3B (UBXN3B) 303 , and RNF115 59 also conjugate K63-linked polyubiquitin chains to STING, thereby strengthening its interaction with IRF3 and TBK1. The E3 ubiquitin ligase complex AMFR and insulin-induced gene 1 (INSIG1) catalyze K27-linked polyubiquitination of STING. This modification acts as an anchoring platform for recruitment of TBK1, thereby facilitating its translocation to perinuclear microsomes 304 . K48-linked polyubiquitination is one of the main negative regulatory mechanisms of cellular STING protein expression. Therefore, any factor that disrupts the K48-linked polyubiquitin chain may activate signal transduction. The DUBs USP20/ USP18 305, 306 , USP44 307 , CYLD 308 , OTUD5 309 , and iRhom2 310 remove K48-linked polyubiquitin chains from STING and ultimately boost innate antiviral responses. Palmitoylation plays an important role in regulating protein transport, stability, and cellular localization in host cells. Palmitoylation of STING occurs after its trafficking to the Golgi apparatus; this PTM is essential for activation of STING. Moreover, the palmitoylation inhibitor 2-bromopalmitate (2-BP) impairs STING-mediated IFN induction 311, 312 . Phosphorylation of STING by TBK1 at S366 promotes the recruitment and activation of IRF3 313 . Moreover, S358 of STING is also phosphorylated, although the kinase responsible is not known 314 . Interestingly, upon DNA virus infection, the tyrosine kinase CSK phosphorylates STING at Y240 and Y245, which is important for its activation 315 . The ER-associated proteins ZDHHC1 and transmembrane emp24 protein transport domain-containing 2 (TMED2) associate with STING and mediate its dimerization/ aggregation; they also facilitate its trafficking 315, 316 . SNX8 recruits the class III phosphatidylinositol 3-kinase protein VPS34 to STING, thereby facilitating the trafficking of STING from the ER to perinuclear microsomes 317 .

With respect to the negative regulation of STING, RNF5 impairs STING signaling by modifying it at K150 through K48-linked polyubiquitination, which promotes its degradation 318 . RNF90 and TRIM29 also promote K48-linked ubiquitination of STING and impair STING signaling 319, 320 ; however, the specific aa residue 1 that is ubiquitinated is not defined. Moreover, TRIM30α negatively regulates the STING pathway via K48-linked ubiquitination of STING on K275 321 . In contrast, the DUB USP21 hydrolyzes K27/63linked polyubiquitin chains 322 , USP49 323 removes K63-linked polyubiquitin chains, and USP13 324 removes K33-linked polyubiquitin chains on STING to negatively regulate STING-mediated signaling. PPM1A dephosphorylates STING at S358 and suppresses the formation of perinuclear puncta, thereby suppressing immune responses 314 . Phosphorylation of Y245 on STING is critical for STING activation. PTPN1 and PTPN2 dephosphorylate STING at Y245 and then promote its degradation via the 20 S proteasome 325 . Additionally, MRP 326 and NLRX1 327 interact with STING to downregulate its function, while RIG-I and IL-6 trigger proteasomal degradation of STING in human diploid cells upon dsDNA stimulation 328 . Autophagy-related gene 9a (Atg9a) colocalizes with STING to disrupt the binding of STING to TBK1 329 .

STING plays a critical role in the host defense against infections with DNA viruses such as HSV-1, vaccinia virus (VVΔE3L), cytomegalovirus (CMV), and baculoviruses 330 . Therefore, viruses have evolved certain strategies to defeat host innate immunity by antagonizing STING signaling. For example, the ICP27 331 protein of HSV is translocated to the cytoplasm during infection, where it interacts with STING and inhibits IRF3 activation. The HSV-1 γ34.5 protein downregulates STING trafficking from the ER to the Golgi by interacting with the N-terminus of STING 332 , while UL46 of HSV-1, one of the most abundant HSV tegument proteins, interacts with STING to prevent its activation 333 . The HSV-1 VP1-2 protein deubiquitinates STING and inhibits its downstream signaling 334 . The human T lymphotropic virus type 1 (HTLV-1) Tax protein also deubiquitinates STING to inhibit its downstream signaling 22 , while NS4B of HCV cleaves STING directly 335 , and vIRF1 of KSHV impairs the STING/TBK1 interaction 336 . Murine CMV (MCMV) encodes a product referred to as M152, which interacts with STING to suppress its activation 337 . The viral polymerase of HBV interferes with K63-linked polyubiquitination of STING via its reverse transcriptase domain 338 . The HCMV tegument protein UL82 negatively regulates STING signaling by interacting directly with STING. It then inhibits STING trafficking from the ER to perinuclear punctate structures 339 . The IE86 protein of HCMV facilitates proteasome-dependent degradation of STING to suppress the secretion of IFN-β1 and CXCL10 340, 341 , and UL42 of HCMV impairs the translocation of STING from the ER to perinuclear punctate structures, which is required for STING activation 342 . Duck Tembusu virus (DTMUV) NS2B3 cleaves STING by interacting with aa residues 221-225; this method of STING cleavage is not strictly species-specific 343 .

To complete their life cycles in the host, DNA viruses use numerous strategies to evade host immune signaling initiated by RLRs; they do this by targeting TBK1. The Us11 protein of HSV-1 associates with endogenous Hsp90 to disrupt the Hsp90/TBK1 complex, which blocks TBK1 activation. Furthermore, Us11 induces destabilization of TBK1 through a proteasome-dependent pathway that ultimately blocks phosphorylation of IRF 3 196 . In addition, the UL46 protein of HSV-1 interacts with the C-terminal region of TBK1 to inhibit the interaction of TBK1 and STING 333 , whereas the gamma(1)34.5 protein forms a complex with TBK1 and disrupts the TBK1/IRF3 interaction, thereby preventing downstream signaling 344 . ORF11 of murine gammaherpesvirus 68 (MHV-68) interacts directly with TBK1; in particular, it inhibits the TBK1/IRF3 interaction 345 . The C-terminus and the coiled-coil domain of feline panleukopenia virus (FPV) NS2 interact physically with TBK1, thereby preventing it from being recruited by STING; ultimately, this disrupts the phosphorylation of the downstream protein IRF3 346 .

A number of DNA viral proteins inhibit IRF3 to suppress innate immune signaling. The VP24 protein of HSV-1 and the LANA2 (also called vIRF3) protein of Kaposi's sarcoma-associated herpesvirus (KHSV) limit the induction of IFN-β by interacting with IRF3 to inhibit its dimerization and phosphorylation 29, 347 . The ICP0 protein (bICP0) encoded by bovine herpesvirus 1 (BoHV-1) induces proteasomal degradation of IRF3 but not IRF7 348 . Varicella-zoster virus (VZV) is an important alpha herpesvirus that infects only humans. Several VZV viral proteins interfere with IRF3 activity. VZV viral immediate-early protein 62 (IE62) inhibits IRF3 phosphorylation at key serine residues but does not interfere with the IRF3/TBK1 interaction 349 . ORF47 interacts directly with IRF3, thereby inhibiting subsequent signal transduction, while ORF61 interacts directly with IRF3 and induces its ubiquitination and proteasomal degradation 350, 351 . The nuclear early protein N2 of vaccinia virus inhibits the phosphorylation and nuclear translocation of IRF3 351 .

Different viral proteins inhibit and activate IRF7. The interaction of the Epstein-Barr virus oncoprotein LMP1 with IRF7 catalyzes RIPdependent K63-linked polyubiquitination and subsequent activation of IRF7 352 . The VP23 protein of Marek's disease virus interacts with IRF7 and blocks its binding to TBK1, thereby inhibiting IRF7 phosphorylation and nuclear translocation, resulting in reduced IFN-β production 353 . The immediate-early nuclear transcription factor RTA encoded by KSHV and HHV8 acts as an ubiquitin E3 ligase to catalyze the polyubiquitination and proteasomal degradation of IRF7 354 . KSHV vIRF3 interacts specifically with either the DBD or the central IAD of IRF7, which inhibits the DNA binding activity of IRF7 355 . KSHV vIRF4 interacts specifically with IRF7, thereby inhibiting IRF7 dimerization and ultimately suppressing IRF7-mediated activation of type I IFNs 356 . LANA2 (also called vIRF3) of KSHV limits the induction of IFN-β by interacting with IRF7 and inhibiting its phosphorylation 29 .

Over the past few decades, tremendous research progress has been made in identifying and characterizing two antiviral innate immunity pathways: the RLR-MAVS pathway for cytoplasmic RNA sensing and the cGAS-cGAMP-STING pathway for cytosolic DNA recognition. In this review, we summarize the current knowledge of the mechanisms that positively and negatively regulate PRR-mediated immune responses. We also discuss the molecules involved in the two abovementioned signaling pathways, which maintain immune homeostasis to achieve the most favorable outcome for the host. Finally, we explain how viral proteins adapt to escape host antiviral mechanisms to maintain active infection.

Due to advanced biomedical techniques such as fluorescence imaging, mass spectrometry, and nuclear magnetic resonance imaging, we now know much more about the molecular mechanisms and the host and viral factors that regulate signaling. Moreover, each new regulatory and molecular mechanism identified brings the inspiring possibility that we may identify and develop novel immunostimulatory agents, anti-inflammatory agents, vaccines, and antiviral agents that tilt the host-pathogen interaction in favor of the host. Despite tremendous advances in our knowledge regarding the functions and mechanisms of positive and negative regulatory molecules and of escape mechanisms used by viruses to evade innate immune signaling, several intriguing and important aspects regarding the regulation of RNA-and (especially) DNAinitiated signaling pathways and viral escape mechanisms remain elusive. These will be interesting topics for future investigations.

Post-translation regulation of influenza virus replication

Intracellular sensing of viral genomes and viral evasion

Importance of nucleic acid recognition in inflammation and autoimmunity

Regulation of type I interferon responses

Activation and regulation of interferon-β in immune responses

Post-translational regulation of antiviral innate signaling

Post-translational modifications in signal integration

Unconventional post-translational modifications in immunological signaling

Pathogen recognition and inflammatory signaling in innate immune defenses

Viral evasion of intracellular DNA and RNA sensing

Post-translational modification control of innate immunity

Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation

Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems

Regulatory functions of ubiquitination in the immune system

The role of ubiquitylation in immune defence and pathogen evasion

The ubiquitin code

The increasing complexity of the ubiquitin code

Lysine acetylation targets protein complexes and coregulates major cellular functions

Proteases and protease inhibitors in infectious diseases

Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses

The matrix protein of human parainfluenza virus type 3 induces mitophagy that suppresses interferon responses

HTLV-1 Tax impairs K63-linked ubiquitination of STING to evade host innate immunity

Ovarian tumor domain-containing viral proteases evade ubiquitin-and ISG15-dependent innate immune responses

GCRV hijacks TBK1 to evade IRF7-mediated antiviral immune responses in grass carp Ctenopharyngodon idella. Fish. Shellfish Immunol

NLRX1 mediates MAVS degradation to attenuate the hepatitis C virus-induced innate immune response through PCBP2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling

Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/ IKKepsilon complex

Ten Strategies of Interferon Evasion by Viruses

Kaposi's sarcomaassociated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7

RNA recognition and signal transduction by RIG-I-like receptors

Immune signaling by RIG-I-like receptors

The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response

VISA is an adapter protein required for virus-triggered IFN-beta signaling

IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction

The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

Jr Mitochondrialassociated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus

Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus

Peroxisomes are signaling platforms for antiviral innate immunity

Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase

MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response

The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection

The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination

O-GlcNAc transferase links glucose metabolism to MAVS-mediated antiviral innate immunity

TRIM21 promotes innate immune response to RNA viral infection through Lys27-linked polyubiquitination of MAVS

PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4

Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS

MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors

Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses

A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response

Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1

NAC1 potentiates cellular antiviral signaling by bridging MAVS and TBK1

Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling

c-Abl tyrosine kinase interacts with MAVS and regulates innate immune response

RNF115 plays dual roles in innate antiviral responses by catalyzing distinct ubiquitination of MAVS and MITA

Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation

HSPD1 interacts with IRF3 to facilitate interferon-beta induction

pVHL Negatively Regulates Antiviral Signaling by Targeting MAVS for Proteasomal Degradation

The mitochondrial ubiquitin ligase MARCH5 resolves MAVS aggregates during antiviral signalling

The otubain YOD1 suppresses aggregation and activation of the signaling adaptor MAVS through Lys63-linked deubiquitination

Poly(C)-binding protein 1 (PCBP1) mediates housekeeping degradation of mitochondrial antiviral signaling (MAVS)

TAX1BP1 restrains virus-induced apoptosis by facilitating itch-mediated degradation of the mitochondrial adaptor MAVS

Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/ TRAF6 signalosome

Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125

Tetherin suppresses type I interferon signaling by targeting MAVS for NDP52-mediated selective autophagic degradation in human cells

Phosphorylation of MAVS/VISA by nemo-like kinase (NLK) for degradation regulates the antiviral innate immune response

PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1

Lactate is a natural suppressor of RLR signaling by targeting MAVS

TTLL12 inhibits the activation of cellular antiviral signaling through interaction with VISA/MAVS

UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS

RNA-and virus-independent inhibition of antiviral signaling by RNA helicase LGP2

GPATCH3 negatively regulates RLR-mediated innate antiviral responses by disrupting the assembly of VISA signalosome

Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS

Control of antiviral innate immune response by protein geranylgeranylation

Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria

Mitofusin 2 inhibits mitochondrial antiviral signaling

Negative regulation of MAVS-mediated innate immune response by ASC

Negative regulation of MAVS-mediated innate immune response by PSMA7

Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses

The suppression of innate immune response by human rhinovirus C

The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling

Seneca valley virus suppresses host type I interferon production by targeting adaptor proteins MAVS, TRIF, and TANK for cleavage

Enterovirus 2Apro targets MDA5 and MAVS in infected cells

Porcine reproductive and respiratory syndrome virus 3C protease cleaves the mitochondrial antiviral signalling complex to antagonize IFN-β expression

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies

Antibacterial effect of hexane extract of sea urchin, Temnopleurus alexandri (Bell, 1884)

Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor

MAVS protein is attenuated by rotavirus nonstructural protein 1

Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells

The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein

Hepatitis B virus-induced parkindependent recruitment of linear ubiquitin assembly complex (LUBAC) to mitochondria and attenuation of innate immunity

SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome

GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation

Negative regulation of mitochondrial antiviral signaling proteinmediated antiviral signaling by the mitochondrial protein LRPPRC during hepatitis C virus infection

Possible role of the Nipah virus V protein in the regulation of the interferon beta induction by interacting with UBX domain-containing protein1

Foot-and-mouth disease virus VP1 target the MAVS to inhibit type-I interferon signaling and VP1 E83K mutation results in virus attenuation

Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection

Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS

Functional motifs responsible for human metapneumovirus M2-2-mediated innate immune evasion

SARS-CoV-2 membrane glycoprotein M antagonizes the MAVSmediated innate antiviral response

Tumor necrosis factor receptorassociated factors (TRAFs)-a family of adapter proteins that regulates life and death

All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction

The signaling adaptors and pathways activated by TNF superfamily

Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling

DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS

Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response

Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex

TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination

TRIM35 mediates protection against influenza infection by activating TRAF3 and degrading viral PB2

Ring finger protein 166 potentiates RNA virus-induced interferon-β production via enhancing the ubiquitination of TRAF3 and TRAF6

The kinase CK1ɛ controls the antiviral immune response by phosphorylating the signaling adaptor TRAF3

Intracellular osteopontin stabilizes TRAF3 to positively regulate innate antiviral response

DOK3 is required for IFN-β production by enabling TRAF3/TBK1 complex formation and IRF3 activation

The small GTPase RAB1B promotes antiviral innate immunity by interacting with TNF receptor-associated factor 3 (TRAF3)

Deubiquitinase MYSM1 regulates innate immunity through inactivation of TRAF3 and TRAF6 complexes

DUBA: a deubiquitinase that regulates type I interferon production

USP19 suppresses cellular type I interferon signaling by targeting TRAF3 for deubiquitination

Regulation of virus-triggered signaling by OTUB1-and OTUB2-mediated deubiquitination of TRAF3 and TRAF6

Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte's innate immune response

FOSL1 inhibits Type I interferon responses to malaria and viral infections by blocking TBK1 and TRAF3/TRIF interactions

HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1

Scavenger receptor A impairs interferon response to HBV infection by limiting TRAF3 ubiquitination through recruiting OTUB1

Estrogen receptor alpha inhibits RLR-mediated immune response via ubiquitinating TRAF3

WDR82 negatively regulates cellular antiviral response by mediating TRAF3 polyubiquitination in multiple cell lines

Parkin negatively regulates the antiviral signaling pathway by targeting TRAF3 for degradation

The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/ MAVS signaling pathway by targeting TRAF3 for degradation

Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex

The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase

Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3

Enterovirus D68 protease 2A(pro) targets TRAF3 to subvert host innate immune responses

The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways

Regulation and function of IKK and IKK-related kinases

NEMO binds ubiquitinated TANK-binding kinase 1 (TBK1) to regulate innate immune responses to RNA viruses

Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense

Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2

Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract

Inducible Rubicon facilitates viral replication by antagonizing interferon production

Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling

Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling

Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon

Porcine reproductive and respiratory syndrome virus nonstructural protein 4 antagonizes beta interferon expression by targeting the NF-κB essential modulator

Arterivirus nsp4 antagonizes interferon beta production by proteolytically cleaving NEMO at multiple sites

Feline infectious peritonitis virus Nsp5 inhibits type I interferon production by cleaving NEMO at multiple sites

Porcine epidemic diarrhea virus 3C-like protease regulates its interferon antagonism by cleaving NEMO

Porcine deltacoronavirus nsp5 inhibits interferon-β production through the cleavage of NEMO

SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO

NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase

Innate immunity to virus infection

Structure and ubiquitination-dependent activation of TANK-binding kinase 1

Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation

Glycogen synthase kinase 3β regulates IRF3 transcription factormediated antiviral response via activation of the kinase TBK1

TRIM9 short isoform preferentially promotes DNA and RNA virusinduced production of type I interferon by recruiting GSK3β to TBK1

RKIP and TBK1 form a positive feedback loop to promote type I interferon production in innate immunity

UBQLN2 Promotes the production of type I interferon via the TBK1-IRF3 PAthway

The tyrosine kinase Src promotes phosphorylation of the kinase TBK1 to facilitate type I interferon production after viral infection

Mapping a dynamic innate immunity protein interaction network regulating type I interferon production

E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1

The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLRmediated production of type I interferon

USP1-UAF1 deubiquitinase complex stabilizes TBK1 and enhances antiviral responses

Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity

Histone deacetylase 3 promotes innate antiviral immunity through deacetylation of TBK1

MAP4-regulated dynein-dependent trafficking of BTN3A1 controls the TBK1-IRF3 signaling axis

IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1

Autoubiquitination of TRIM26 links TBK1 to NEMO in RLR-mediated innate antiviral immune response

MSX1 modulates RLR-mediated innate antiviral signaling by facilitating assembly of TBK1-associated complexes

PLA1A participates in the antiviral innate immune response by facilitating the recruitment of TANK-binding kinase 1 to mitochondria

E3 ubiquitin ligase ASB8 negatively regulates interferon via regulating TBK1/IKKi homeostasis

TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1

DYRK2 negatively regulates type I interferon induction by promoting TBK1 degradation via Ser527 phosphorylation

THO complex subunit 7 homolog negatively regulates cellular antiviral response against RNA. Viruses Target. TBK1. Viruses

USP38 inhibits Type I interferon signaling by editing TBK1 ubiquitination through NLRP4 signalosome

Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27

NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4

TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases

Ubiquitin-specific protease 2b negatively regulates IFN-β production and antiviral activity by targeting TANKbinding kinase 1

Ubiquitin-conjugating enzyme 2S enhances viral replication by inhibiting type I IFN production through recruiting USP15 to deubiquitinate TBK1

Lck/Hck/Fgr-mediated tyrosine phosphorylation negatively regulates TBK1 to restrain innate antiviral responses

Constitutive aryl hydrocarbon receptor signaling constrains type I interferon-mediated antiviral innate defense

Phosphatase Cdc25A negatively regulates the antiviral immune response by inhibiting TBK1 activity

PPM1B negatively regulates antiviral response via dephosphorylating TBK1

Phosphatase PP4 negatively regulates type I IFN production and antiviral innate immunity by dephosphorylating and deactivating TBK1

NLRP2 negatively regulates antiviral immunity by interacting with TBK1

ERRα negatively regulates type I interferon induction by inhibiting TBK1-IRF3 interaction

MIP-T3 is a negative regulator of innate type I IFN response

ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response

Induction of INKIT by viral infection negatively regulates antiviral responses through inhibiting phosphorylation of p65 and IRF3

Evasion of type I interferon by SARS-CoV-2

Differential antagonism of human innate immune responses by tick-borne phlebovirus nonstructural proteins

Dengue virus NS proteins inhibit RIG-I/MAVS signaling by blocking TBK1/IRF3 phosphorylation: dengue virus serotype 1 NS4A is a unique interferon-regulating virulence determinant

PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway

Herpes simplex virus 1 Inhibits TANK-binding kinase 1 through formation of the Us11-Hsp90 complex

Evasion of antiviral immunity through sequestering of TBK1/IKKε/ IRF3 into viral inclusion bodies

Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform

Two conserved amino acids within the NSs of severe fever with thrombocytopenia syndrome phlebovirus are essential for anti-interferon activity

Porcine epidemic diarrhea virus nucleocapsid protein antagonizes beta interferon production by sequestering the interaction between IRF3 and TBK1

Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase-IRF3 transcription factor interaction and signaling required for interferon induction

Zika virus NS5 protein antagonizes type I interferon production via blocking TBK1 activation

SARS-CoV-2 non-structural protein 13 (nsp13) hijacks host deubiquitinase USP13 and counteracts host antiviral immune response

SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex

Inhibition of interferon gene activation by death-effector domain-containing proteins from the molluscum contagiosum virus

Roles for the IKK-related kinases TBK1 and IKKε in cancer

The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling

Sphingosine 1-phosphate lyase enhances the activation of IKKε to promote type I IFN-mediated innate immune responses to influenza A virus infection

Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation

DDX19 inhibits type I interferon production by disrupting TBK1-IKKε-IRF3 interactions and promoting TBK1 and IKKε degradation

Fascin1 suppresses RIG-I-like receptor signaling and interferon-β production by associating with IκB kinase ϵ (IKKϵ) in colon cancer

Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction

Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions

Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1

Arenavirus nucleoprotein targets interferon regulatory factoractivating kinase IKKε

Middle east respiratory syndrome coronavirus ORF8b accessory protein suppresses type I IFN expression by impeding HSP70-dependent activation of IRF3 kinase IKKε

IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA

Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change

Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation

Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylation

IRF1 promotes the innate immune response to viral infection by enhancing the activation of IRF3

The methyltransferase NSD3 promotes antiviral innate immunity via direct lysine methylation of IRF3

USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2

Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1

Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3

The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3

Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation

The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3

TRIM26 negatively regulates interferon-β production and antiviral response through polyubiquitination and degradation of nuclear IRF3

OTUD1 negatively regulates type I IFN induction by disrupting noncanonical ubiquitination of IRF3

IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3

MAPK phosphatase 5 expression induced by influenza and other RNA virus infection negatively regulates IRF3 activation and type I interferon response

Recruitment of phosphatase PP2A by RACK1 adaptor protein deactivates transcription factor IRF3 and limits type I interferon signaling

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation

A novel function of F-Box protein FBXO17 in negative regulation of type I IFN signaling by recruiting PP2A for IFN regulatory factor 3 deactivation

RNA helicase DDX5 suppresses IFN-I antiviral innate immune response by interacting with PP2A-Cβ to deactivate IRF3

Host HDAC4 regulates the antiviral response by inhibiting the phosphorylation of IRF3

SENP2 negatively regulates cellular antiviral response by deSU-MOylating IRF3 and conditioning it for ubiquitination and degradation

DDX56 inhibits type I interferon by disrupting assembly of IRF3-IPO5 to inhibit IRF3 nucleus import

Rubicon modulates antiviral type I interferon (IFN) signaling by targeting IFN regulatory factor 3 dimerization

AGO2 negatively regulates type I interferon signaling pathway by competition binding IRF3 with CBP/p300. Front

Role of N terminus-truncated NS1 proteins of influenza A virus in inhibiting IRF3 activation

Porcine haemagglutinating encephalomyelitis virus deactivates transcription factor IRF3 and limits type I interferon production

Genetic dissection of interferon-antagonistic functions of rabies virus phosphoprotein: inhibition of interferon regulatory factor 3 activation is important for pathogenicity

The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity

Peste des petits ruminants virus nucleocapsid protein inhibits beta interferon production by interacting with IRF3 to block its activation

Porcine epidemic diarrhea virus nsp15 antagonizes interferon signaling by RNA degradation of TBK1 and IRF3

Activation and evasion of type I interferon responses by SARS-CoV-2

SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation

SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3

SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species

Japanese encephalitis virus NS5 inhibits type I interferon (IFN) production by blocking the nuclear translocation of IFN regulatory factor 3 and NF-κB

Japanese encephalitis virus non-coding RNA inhibits activation of interferon by blocking nuclear translocation of interferon regulatory factor 3

Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein

Seneca Valley Virus 3C(pro) abrogates the IRF3-and IRF7-mediated innate immune response by degrading IRF3 and IRF7

Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation

Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3

DDX56 cooperates with FMDV 3A to enhance FMDV replication by inhibiting the phosphorylation of IRF3

Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation

Suppression of type I interferon production by human T-cell leukemia virus type 1 oncoprotein tax through inhibition of IRF3 phosphorylation

Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3

Thogoto virus ML protein suppresses IRF3 function

Rotavirus NSP1 mediates degradation of interferon regulatory factors through targeting of the dimerization domain

Jr Structural insights into interferon regulatory factor activation

IRF-7 is the master regulator of type-I interferon-dependent immune responses

The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection

Positive feedback regulation of type I IFN genes by the IFNinducible transcription factor IRF-7

TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1

Negative regulation of Nmi on virus-triggered type I IFN production by targeting IRF7

Self protection from anti-viral responses-Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors

Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7

P200 family protein IFI204 negatively regulates type I interferon responses by targeting IRF7 in nucleus

Negative regulation of IRF7 activation by activating transcription factor 4 suggests a cross-regulation between the IFN responses and the cellular integrated stress responses

Negative regulation of IKKε-mediated IRF7 phosphorylation by HSP70

Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery

Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes

Classical swine fever virus N(pro) limits type I interferon induction in plasmacytoid dendritic cells by interacting with interferon regulatory factor 7

Cyclic GMP-AMP as an endogenous second messenger in innate immune signaling by cytosolic DNA

Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING

STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling

cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING

The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

The AIM2-like receptors are dispensable for the interferon response to intracellular DNA

Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA

Cyclic (di)nucleotides: the common language shared by microbe and host

Transfer of cGAMP into bystander cells via LRRC8 volumeregulated anion channels augments STING-mediated interferon responses and anti-viral immunity

Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs

Structural insights into cGAMP degradation by ecto-nucleotide pyrophosphatase phosphodiesterase 1

Viruses transfer the antiviral second messenger cGAMP between cells

Transmission of innate immune signaling by packaging of cGAMP in viral particles

Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling

Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP

STING and the innate immune response to nucleic acids in the cytosol

Structural basis of STING binding with and phosphorylation by TBK1

Structural insights into STING signaling

STING signaling the enERGIC way

Ubiquitination of STING at lysine 224 controls IRF3 activation

Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-κB signaling after nuclear DNA damage

UBXN3B positively regulates STING-mediated antiviral immune responses

The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING

USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA

USP20 promotes cellular antiviral responses via deconjugating K48-linked ubiquitination of MITA

USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA

The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway

OTUD5 promotes innate antiviral and antitumor immunity through deubiquitinating and stabilizing STING

iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING

STING palmitoylation as a therapeutic target

Activation of STING requires palmitoylation at the Golgi

Cyclic dinucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling

PPM1A regulates antiviral signaling by antagonizing TBK1-mediated STING phosphorylation and aggregation

CSK promotes innate immune response to DNA virus by phosphorylating MITA

TMED2 potentiates cellular IFN responses to DNA viruses by reinforcing MITA dimerization and facilitating Its trafficking

SNX8 modulates innate immune response to DNA virus by mediating trafficking and activation of MITA

The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA

RNF90 negatively regulates cellular antiviral responses by targeting MITA for degradation

TRIM29 negatively controls antiviral immune response through targeting STING for degradation

TRIM30α is a negative-feedback regulator of the intracellular DNA and DNA virus-triggered response by targeting STING

p38 inhibition provides anti-DNA virus immunity by regulation of USP21 phosphorylation and STING activation

USP49 negatively regulates cellular antiviral responses via deconjugating K63-linked ubiquitination of MITA

USP13 negatively regulates antiviral responses by deubiquitinating STING

PTPN1/2-mediated dephosphorylation of MITA/STING promotes its 20S proteasomal degradation and attenuates innate antiviral response

An alternative splicing isoform of MITA antagonizes MITAmediated induction of type I IFNs

NLRX1 sequesters STING to negatively regulate the interferon response, thereby facilitating the replication of HIV-1 and DNA viruses

RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA

Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response

STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity

HSV-1 ICP27 targets the TBK1-activated STING signalsome to inhibit virus-induced type I IFN expression

Herpes simplex virus 1 γ(1)34.5 protein inhibits STING activation that restricts viral replication

Evasion of the STING DNA-sensing pathway by VP11/12 of herpes simplex virus 1

HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection

Hepatitis C virus NS4B can suppress STING accumulation to evade innate immune responses

Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses

The herpesviral antagonist m152 reveals differential activation of STING-dependent IRF and NF-κB signaling and STING's dual role during MCMV infection

Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways

Human cytomegalovirus tegument protein UL82 inhibits STINGmediated signaling to evade antiviral immunity

Human cytomegalovirus IE2 86 kDa protein induces STING degradation and inhibits cGAMP-mediated IFN-β induction

Human cytomegalovirus IE86 protein aa 136-289 mediates STING degradation and blocks the cGAS-STING pathway

Human cytomegalovirus protein UL42 antagonizes cGAS/MITAmediated innate antiviral response

Binding of the duck tembusu virus protease to STING is mediated by NS2B and is crucial for STING cleavage and for impaired induction of IFN-β

Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1

Murine gammaherpesvirus 68 encoding open reading frame 11 targets TANK binding kinase 1 to negatively regulate the host type I interferon response

Feline panleucopenia virus NS2 suppresses the host IFN-β induction by disrupting the interaction between TBK1 and STING

Herpes simplex virus 1 serine protease VP24 blocks the DNA-sensing signal pathway by abrogating activation of interferon regulatory factor 3

The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity

Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses

The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3

Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3

Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination

Inhibition of DNA-sensing pathway by Marek's disease virus VP23 protein through suppression of interferon regulatory factor 7 activation

The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosomemediated degradation

Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3

KSHV-encoded viral interferon regulatory factor 4 (vIRF4) interacts with IRF7 and inhibits interferon alpha production

The authors declare no competing interests.

Correspondence and requests for materials should be addressed to Jong-Soo Lee.Reprints and permission information is available at http://www.nature.com/ reprintsPublisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. org/licenses/by/4.0/.